Cas:864068-82-6 N-(IMIDAZO[1,2-A]PYRIDIN-6-YLMETHYL)-N-METHYLAMINE manufacturer & supplier

We serve Chemical Name:N-(IMIDAZO[1,2-A]PYRIDIN-6-YLMETHYL)-N-METHYLAMINE CAS:864068-82-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(IMIDAZO[1,2-A]PYRIDIN-6-YLMETHYL)-N-METHYLAMINE

Chemical Name:N-(IMIDAZO[1,2-A]PYRIDIN-6-YLMETHYL)-N-METHYLAMINE
CAS.NO:864068-82-6
Synonyms:{imidazo[1,2-a]pyridin-6-ylmethyl}(methyl)amine;N-(Imidazo[1,2-a]pyridin-6-ylmethyl)-N-methylamine
Molecular Formula:C9H11N3
Molecular Weight:161.20400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.15g/cm3
Index of Refraction:1.615
PSA:29.33000
Exact Mass:161.09500
LogP:1.44460

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like {imidazo[1,2-a]pyridin-6-ylmethyl}(methyl)amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(Imidazo[1,2-a]pyridin-6-ylmethyl)-N-methylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,{imidazo[1,2-a]pyridin-6-ylmethyl}(methyl)amine Use and application,{imidazo[1,2-a]pyridin-6-ylmethyl}(methyl)amine technical grade,usp/ep/jp grade.


Related News: The group of diseases known as severe combined immunodeficiency, or SCID, first drew wide attention decades ago because of David Vetter, a boy born with X-linked SCID who lived in a bubble for 12 years as doctors tried to figure out how to cure him. 4-(1-(4-methylthiophen-3-yl)propyl)-1H-imidazole manufacturers Pfizer said on Wednesday it believes people need the additional dose to keep protection against the coronavirus high. The company says it could apply for U.S. emergency authorization for booster shots as early as August. read more Elongation factor Tu (Buchnera aphicicola strain Baizongia pistaciaegene tuf) suppliers The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. 2-chloro-5-(3,5-dichloro-2-methoxy-phenyl)-pyrrole-3,4-dicarboxylic acid diethyl ester vendor & factory.